1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Lecoq, L. Omichinski, J.G. Raiola, L. Cyr, N. Chabot, P. Arseneault, G. Legault, P. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK Nucleic Acids Res. NARHAD 0389 1362-4962 45 5564 5576 10.1093/nar/gkx146 28334776 Structural characterization of interactions between transactivation domain 1 of the p65 subunit of NF-kappa B and transcription regulatory factors. 2017 10.2210/pdb5urn/pdb pdb_00005urn 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 12903.701 RNA polymerase II transcription factor B subunit 1 PLECKSTRIN HOMOLOGY DOMAIN, UNP RESIDUES 2-115 1 man polymer The first GS residues come from a purification TAG. 3378.591 Transcription factor p65 TRANSACTIVATION DOMAIN 1, UNP RESIDUES 521-551 L523Y 1 man polymer General transcription and DNA repair factor IIH subunit TFB1,TFIIH subunit TFB1,RNA polymerase II transcription factor B 73 kDa subunit,RNA polymerase II transcription factor B p73 subunit Nuclear factor NF-kappa-B p65 subunit,Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3 no no PSHSGAAIFEKVSGIIAINEDVSPAELTWRSTDGDKVHTVVLSTIDKLQATPASSEKMMLRLIGKVDESKKRKDNEGNEV VPKPQRHMFSFNNRTVMDNIKMTLQQIISRYKDAD PSHSGAAIFEKVSGIIAINEDVSPAELTWRSTDGDKVHTVVLSTIDKLQATPASSEKMMLRLIGKVDESKKRKDNEGNEV VPKPQRHMFSFNNRTVMDNIKMTLQQIISRYKDAD A polypeptide(L) no no GSPGYPNGLLSGDEDFSSIADMDFSALLSQISS GSPGYPNGLLSGDEDFSSIADMDFSALLSQISS B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Baker's yeast ATCC 204508 / S288c sample 1 115 TFB1, YDR311W, D9740.3 559292 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 562 Escherichia coli PGEX-TEV Biological sequence Human sample 1 33 RELA, NFKB3 9606 Homo sapiens 562 Escherichia coli PGEX-TEV Biological sequence database_2 pdbx_database_status pdbx_nmr_software repository Initial release Derived calculations Database references Database references Data collection Database references Other 1 0 2017-03-08 1 1 2017-03-22 1 2 2017-04-05 1 3 2017-05-31 1 4 2023-06-14 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.status_code_nmr_data _pdbx_nmr_software.name 2017-03-08 SPRSDE CHEMICAL SHIFTS OF FREE TFB1 NMR STRUCTURE OF THE PH DOMAIN OF TFB1 NMR STRUCTURE OF TFB1 IN COMPLEX WITH ACTIVATION DOMAIN OF P53 NMR STRUCTURE OF TFB1 IN COMPLEX WITH ACTIVATION DOMAIN OF VP16 NMR STRUCTURE OF TFB1 IN COMPLEX WITH ACTIVATION DOMAIN OF EKLF NMR STRUCTURE OF TFB1 IN COMPLEX WITH RAD2 NMR STRUCTURE OF TFB1 IN COMPLEX WITH RAD4 NMR structures of the Complex Between the Acidic Transactivation Domain of EBNA2 and the Tfb1 subunit of TFIIH. NMR structure of the complex between the C-terminal domain of the Rift Valley fever virus protein NSs and the PH domain of the Tfb1 subunit of TFIIH NMR structure of the complex between the PH domain of the Tfb1 subunit from TFIIH and the transactivation domain 1 of p65 N RCSB Y RCSB 2017-02-11 REL REL REL REL structures with the lowest energy 260 20 isotropic 1 2D 1H-15N HSQC isotropic 3 2D 1H-13C HSQC aliphatic isotropic 3 2D 1H-13C HSQC aromatic isotropic 1 3D HNCO isotropic 1 3D HNCACB isotropic 1 3D HBHA(CO)NH isotropic 1 3D HCCH-TOCSY isotropic 1 3D 1H-15N NOESY isotropic 3 3D 1H-13C NOESY isotropic 3 3D INTERMOLECULAR NOESY isotropic 1 3D C(CO)NH isotropic 1 2D 1H-15N HSQC isotropic 1 2D 1H-13C HSQC aliphatic isotropic 1 2D 1H-13C HSQC aromatic isotropic 1 3D HNCO isotropic 1 3D HNCACB isotropic 1 3D 1H-15N NOESY isotropic 3 3D 1H-13C NOESY isotropic 3 3D INTERMOLECULAR NOESY 0.8 mM [U-99% 13C; U-99% 15N] 1.6 mM natural abundance 0.8 mM [U-99% 13C; U-99% 15N] 1.6 mM natural abundance 0.8 mM [U-99% 13C; U-99% 15N] 1.6 mM natural abundance 0.8 mM [U-99% 13C; U-99% 15N] 1.6 mM natural abundance 0 mM Condition1 6.5 pH AMBIENT 298 K SIDECHAINS OPTIMIZATION WITH YASARA simulated annealing 1 0.8 mM [U-99% 13C; U-99% 15N] RNA POLYMERASE II TRANSCRIPTION FACTOR B SUBUNIT 1, 1.6 mM TRANSCRIPTION FACTOR P65, 90% H2O/10% D2O 13C-15N labeled Tfb1 with 2 equivalents of unlabeled p65-TA1. Tfb1-p65 90% H2O/10% D2O solution 0.8 mM [U-99% 13C; U-99% 15N] RNA POLYMERASE II TRANSCRIPTION FACTOR B SUBUNIT 1, 1.6 mM TRANSCRIPTION FACTOR P65, 100% D2O 13C-15N labeled Tfb1 with 2 equivalents of unlabeled p65-TA1 in D20. Tfb1-p65-D2O 100% D2O solution 0.8 mM [U-99% 13C; U-99% 15N] TRANSCRIPTION FACTOR P65, 1.6 mM RNA POLYMERASE II TRANSCRIPTION FACTOR B SUBUNIT 1, 90% H2O/10% D2O 13C-15N labeled p65-TA1 with 2 equivalents of unlabeled Tfb1. p65-Tfb1 90% H2O/10% D2O solution 0.8 mM [U-99% 13C; U-99% 15N] TRANSCRIPTION FACTOR P65, 1.6 mM RNA POLYMERASE II TRANSCRIPTION FACTOR B SUBUNIT 1, 100% D2O 13C-15N labeled p65-TA1 with 2 equivalents of unlabeled Tfb1 in D2O. p65-Tfb1-D2O 100% D2O solution BRUNGER A. T. ET.AL. refinement CNS KRIEGER ET AL refinement YASARA structure solution ARIA structure solution CCPNMR structure solution VNMR structure solution NMRPipe 600 Varian INOVA 800 Varian INOVA PRO 1 n 1 PRO 1 A SER 2 n 2 SER 2 A HIS 3 n 3 HIS 3 A SER 4 n 4 SER 4 A GLY 5 n 5 GLY 5 A ALA 6 n 6 ALA 6 A ALA 7 n 7 ALA 7 A ILE 8 n 8 ILE 8 A PHE 9 n 9 PHE 9 A GLU 10 n 10 GLU 10 A LYS 11 n 11 LYS 11 A VAL 12 n 12 VAL 12 A SER 13 n 13 SER 13 A GLY 14 n 14 GLY 14 A ILE 15 n 15 ILE 15 A ILE 16 n 16 ILE 16 A ALA 17 n 17 ALA 17 A ILE 18 n 18 ILE 18 A ASN 19 n 19 ASN 19 A GLU 20 n 20 GLU 20 A ASP 21 n 21 ASP 21 A VAL 22 n 22 VAL 22 A SER 23 n 23 SER 23 A PRO 24 n 24 PRO 24 A ALA 25 n 25 ALA 25 A GLU 26 n 26 GLU 26 A LEU 27 n 27 LEU 27 A THR 28 n 28 THR 28 A TRP 29 n 29 TRP 29 A ARG 30 n 30 ARG 30 A SER 31 n 31 SER 31 A THR 32 n 32 THR 32 A ASP 33 n 33 ASP 33 A GLY 34 n 34 GLY 34 A ASP 35 n 35 ASP 35 A LYS 36 n 36 LYS 36 A VAL 37 n 37 VAL 37 A HIS 38 n 38 HIS 38 A THR 39 n 39 THR 39 A VAL 40 n 40 VAL 40 A VAL 41 n 41 VAL 41 A LEU 42 n 42 LEU 42 A SER 43 n 43 SER 43 A THR 44 n 44 THR 44 A ILE 45 n 45 ILE 45 A ASP 46 n 46 ASP 46 A LYS 47 n 47 LYS 47 A LEU 48 n 48 LEU 48 A GLN 49 n 49 GLN 49 A ALA 50 n 50 ALA 50 A THR 51 n 51 THR 51 A PRO 52 n 52 PRO 52 A ALA 53 n 53 ALA 53 A SER 54 n 54 SER 54 A SER 55 n 55 SER 55 A GLU 56 n 56 GLU 56 A LYS 57 n 57 LYS 57 A MET 58 n 58 MET 58 A MET 59 n 59 MET 59 A LEU 60 n 60 LEU 60 A ARG 61 n 61 ARG 61 A LEU 62 n 62 LEU 62 A ILE 63 n 63 ILE 63 A GLY 64 n 64 GLY 64 A LYS 65 n 65 LYS 65 A VAL 66 n 66 VAL 66 A ASP 67 n 67 ASP 67 A GLU 68 n 68 GLU 68 A SER 69 n 69 SER 69 A LYS 70 n 70 LYS 70 A LYS 71 n 71 LYS 71 A ARG 72 n 72 ARG 72 A LYS 73 n 73 LYS 73 A ASP 74 n 74 ASP 74 A ASN 75 n 75 ASN 75 A GLU 76 n 76 GLU 76 A GLY 77 n 77 GLY 77 A ASN 78 n 78 ASN 78 A GLU 79 n 79 GLU 79 A VAL 80 n 80 VAL 80 A VAL 81 n 81 VAL 81 A PRO 82 n 82 PRO 82 A LYS 83 n 83 LYS 83 A PRO 84 n 84 PRO 84 A GLN 85 n 85 GLN 85 A ARG 86 n 86 ARG 86 A HIS 87 n 87 HIS 87 A MET 88 n 88 MET 88 A PHE 89 n 89 PHE 89 A SER 90 n 90 SER 90 A PHE 91 n 91 PHE 91 A ASN 92 n 92 ASN 92 A ASN 93 n 93 ASN 93 A ARG 94 n 94 ARG 94 A THR 95 n 95 THR 95 A VAL 96 n 96 VAL 96 A MET 97 n 97 MET 97 A ASP 98 n 98 ASP 98 A ASN 99 n 99 ASN 99 A ILE 100 n 100 ILE 100 A LYS 101 n 101 LYS 101 A MET 102 n 102 MET 102 A THR 103 n 103 THR 103 A LEU 104 n 104 LEU 104 A GLN 105 n 105 GLN 105 A GLN 106 n 106 GLN 106 A ILE 107 n 107 ILE 107 A ILE 108 n 108 ILE 108 A SER 109 n 109 SER 109 A ARG 110 n 110 ARG 110 A TYR 111 n 111 TYR 111 A LYS 112 n 112 LYS 112 A ASP 113 n 113 ASP 113 A ALA 114 n 114 ALA 114 A ASP 115 n 115 ASP 115 A GLY 519 n 1 GLY 519 B SER 520 n 2 SER 520 B PRO 521 n 3 PRO 521 B GLY 522 n 4 GLY 522 B TYR 523 n 5 TYR 523 B PRO 524 n 6 PRO 524 B ASN 525 n 7 ASN 525 B GLY 526 n 8 GLY 526 B LEU 527 n 9 LEU 527 B LEU 528 n 10 LEU 528 B SER 529 n 11 SER 529 B GLY 530 n 12 GLY 530 B ASP 531 n 13 ASP 531 B GLU 532 n 14 GLU 532 B ASP 533 n 15 ASP 533 B PHE 534 n 16 PHE 534 B SER 535 n 17 SER 535 B SER 536 n 18 SER 536 B ILE 537 n 19 ILE 537 B ALA 538 n 20 ALA 538 B ASP 539 n 21 ASP 539 B MET 540 n 22 MET 540 B ASP 541 n 23 ASP 541 B PHE 542 n 24 PHE 542 B SER 543 n 25 SER 543 B ALA 544 n 26 ALA 544 B LEU 545 n 27 LEU 545 B LEU 546 n 28 LEU 546 B SER 547 n 29 SER 547 B GLN 548 n 30 GLN 548 B ILE 549 n 31 ILE 549 B SER 550 n 32 SER 550 B SER 551 n 33 SER 551 B author_and_software_defined_assembly PISA 2 dimeric 980 -6 10330 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 identity operation 0.0000000000 0.0000000000 0.0000000000 A N ALA 7 A N ALA 7 A O GLY 14 A O GLY 14 A N ALA 17 A N ALA 17 A O THR 28 A O THR 28 A N LEU 27 A N LEU 27 A O VAL 40 A O VAL 40 A N GLN 49 A N GLN 49 A O ARG 61 A O ARG 61 A N LEU 62 A N LEU 62 A O HIS 87 A O HIS 87 A N ARG 72 A N ARG 72 A O VAL 80 A O VAL 80 1 A A HG H SER GLY 31 34 1.28 1 A A H O LEU VAL 27 40 1.54 1 A A O H GLN ARG 49 61 1.57 2 A A OD1 HG ASP SER 67 69 1.57 2 A A HG OD1 SER ASP 31 35 1.59 3 A A HG H SER LYS 55 57 1.26 4 A B HG HE22 SER GLN 54 548 1.30 5 A A HG OD1 SER ASP 31 35 1.56 6 A A HD2 HG1 HIS THR 3 103 1.33 7 A A O HG1 VAL THR 41 44 1.52 7 A A HG OD1 SER ASP 31 35 1.53 8 A A HG H SER LYS 31 36 1.32 8 A A HB3 HD2 ALA ARG 53 94 1.33 8 A A H O LEU VAL 27 40 1.51 9 B B HG HB2 SER GLU 529 532 1.21 9 A A HG H SER LYS 31 36 1.34 10 A A HG H SER LYS 31 36 1.34 10 A A O H LEU HIS 62 87 1.60 11 A A CB OE2 ASP GLU 74 76 2.10 12 A A HG23 HZ2 VAL LYS 12 36 1.13 13 A B HG HE22 SER GLN 54 548 1.26 13 A A O HG1 VAL THR 41 44 1.49 13 A A HG OD1 SER ASP 31 35 1.51 14 A A HG H SER LYS 31 36 1.33 15 A A HG H SER LYS 31 36 1.29 17 A A H O LEU VAL 27 40 1.52 17 A A HG OD1 SER ASP 31 35 1.59 18 A A HD2 HG1 HIS THR 3 103 1.27 19 A A HG H SER GLY 31 34 1.34 1 A A SER PRO 23 24 -140.01 2 A A SER PRO 23 24 -139.40 3 A A SER PRO 23 24 -142.21 4 A A SER PRO 23 24 -139.53 5 A A SER PRO 23 24 -142.71 6 A A SER PRO 23 24 -139.42 7 A A SER PRO 23 24 -139.00 8 A A SER PRO 23 24 -140.12 9 A A SER PRO 23 24 -142.16 10 A A SER PRO 23 24 -139.41 11 A A SER PRO 23 24 -139.71 12 A A SER PRO 23 24 -140.28 13 A A SER PRO 23 24 -143.48 14 A A SER PRO 23 24 -143.19 15 A A SER PRO 23 24 -142.86 16 A A SER PRO 23 24 -141.44 17 A A SER PRO 23 24 -141.45 18 A A SER PRO 23 24 -141.62 19 A A SER PRO 23 24 -139.40 20 A A SER PRO 23 24 -139.56 1 A A CG CD PRO PRO 1 1 0.202 0.027 1.512 1.714 N 2 B B CE1 CZ PHE PHE 542 542 0.152 0.019 1.369 1.521 N 2 B B CZ CE2 PHE PHE 542 542 -0.136 0.019 1.369 1.233 N 4 A A CG CD PRO PRO 1 1 0.195 0.027 1.512 1.707 N 5 A A CG CD PRO PRO 1 1 0.259 0.027 1.512 1.771 N 5 B B CE1 CZ PHE PHE 542 542 0.140 0.019 1.369 1.509 N 5 B B CZ CE2 PHE PHE 542 542 -0.125 0.019 1.369 1.244 N 6 A A CG CD PRO PRO 1 1 0.175 0.027 1.512 1.687 N 7 A A CG CD PRO PRO 1 1 0.213 0.027 1.512 1.725 N 8 A A CG CD PRO PRO 1 1 0.226 0.027 1.512 1.738 N 9 B B CE1 CZ PHE PHE 542 542 0.124 0.019 1.369 1.493 N 11 A A CG CD PRO PRO 1 1 0.250 0.027 1.512 1.762 N 11 B B CE1 CZ PHE PHE 542 542 0.141 0.019 1.369 1.510 N 11 B B CZ CE2 PHE PHE 542 542 -0.125 0.019 1.369 1.244 N 14 A A CG CD PRO PRO 1 1 0.187 0.027 1.512 1.699 N 16 A A CG CD PRO PRO 1 1 0.186 0.027 1.512 1.698 N 20 B B CE1 CZ PHE PHE 542 542 0.141 0.019 1.369 1.510 N 20 B B CZ CE2 PHE PHE 542 542 -0.123 0.019 1.369 1.246 N 1 A HIS 3 70.71 -31.53 1 A LYS 11 70.61 -6.35 1 A LYS 70 -97.19 34.51 1 A ALA 114 53.76 86.69 1 B SER 529 -149.16 -71.16 1 B ASP 531 -152.80 -26.60 1 B GLN 548 53.60 99.87 2 A LYS 11 70.23 -8.30 2 B SER 520 61.60 120.05 2 B SER 550 61.89 129.91 3 A HIS 3 77.16 -48.83 3 A LYS 11 70.85 -3.01 3 B SER 550 55.66 110.09 4 A LYS 11 55.56 3.47 4 A LYS 70 -92.20 34.36 4 A ALA 114 54.64 88.84 4 B ASN 525 65.08 165.62 4 B SER 529 -165.53 -53.86 4 B GLN 548 53.18 100.03 4 B SER 550 68.67 -58.13 5 A HIS 3 69.78 -31.66 5 A LYS 11 70.07 -5.96 5 A LYS 70 -95.57 36.10 5 A ALA 114 54.18 87.40 5 B SER 520 53.78 111.08 5 B GLN 548 48.34 95.26 6 A LYS 11 68.72 -5.55 6 A LYS 70 -96.70 40.49 6 A ALA 114 54.53 88.06 6 B TYR 523 57.07 92.25 6 B GLN 548 53.41 101.77 7 A HIS 3 69.65 -31.24 7 A LYS 11 68.22 -5.42 7 A LYS 70 -84.11 35.01 7 B TYR 523 57.00 93.93 7 B SER 547 -111.27 69.80 8 A LYS 11 69.24 -3.98 8 A LYS 70 -94.50 37.67 8 B GLN 548 54.33 101.26 8 B ILE 549 -104.28 -61.32 8 B SER 550 58.24 114.82 9 A LYS 11 69.49 -6.18 9 A ALA 114 54.02 87.66 9 B TYR 523 58.07 80.78 9 B ASN 525 42.70 86.54 9 B SER 529 -162.22 -42.97 9 B SER 547 -95.04 39.65 10 A SER 2 60.16 165.12 10 A HIS 3 74.07 -53.06 10 A LYS 11 69.84 -5.15 10 A LYS 70 -91.98 33.54 10 B SER 529 66.64 60.28 11 A LYS 11 68.66 -2.31 11 B SER 529 -134.88 -36.26 11 B GLN 548 -112.73 76.30 12 A LYS 11 70.67 -8.49 12 A ALA 114 54.70 89.33 12 B TYR 523 57.13 85.19 12 B GLN 548 50.10 98.04 13 A HIS 3 69.54 -26.54 13 A LYS 11 71.57 -7.00 13 A ALA 114 53.84 87.40 13 B SER 520 59.45 101.15 13 B SER 529 -155.85 -49.93 13 B GLN 548 52.32 100.41 14 A HIS 3 67.43 -18.20 14 A LYS 11 69.28 -7.46 14 A LYS 70 -97.05 37.98 14 B TYR 523 59.14 88.64 14 B LEU 527 60.69 113.64 14 B SER 529 -154.68 -63.73 14 B SER 547 -106.76 42.70 15 A LYS 11 70.17 -7.42 15 A LYS 70 -99.94 33.19 15 A ALA 114 52.36 83.22 15 B SER 529 -151.58 63.12 15 B GLN 548 51.21 93.15 15 B ILE 549 58.11 78.32 15 B SER 550 61.08 -73.45 16 A HIS 3 67.52 -29.73 16 A LYS 11 70.84 -8.42 16 A ALA 114 54.59 88.67 16 B ASN 525 62.94 116.55 16 B SER 529 -144.38 -53.62 16 B SER 547 -99.42 42.87 17 A LYS 11 69.64 -6.76 17 A ALA 114 55.88 89.64 17 B SER 520 62.01 121.63 17 B LEU 527 58.32 107.89 17 B SER 529 -155.61 42.26 17 B SER 547 -106.22 58.83 18 A LYS 11 69.26 -5.27 18 A LYS 70 -96.14 39.67 18 B GLN 548 52.18 100.52 19 A LYS 11 70.67 -7.54 19 A LYS 70 -87.42 33.64 19 B TYR 523 57.76 92.94 19 B LEU 528 62.43 -15.13 19 B SER 529 -141.28 -58.13 19 B GLN 548 50.33 97.30 20 A LYS 11 69.21 -4.68 20 A ALA 114 53.00 85.08 20 B GLN 548 -102.26 71.67 N NMR structure of the complex between the PH domain of the Tfb1 subunit from TFIIH and the transactivation domain 1 of p65 1 N N 2 N N A ASN 93 A ASN 93 HELX_P A ALA 114 A ALA 114 1 AA1 22 B PHE 534 B PHE 16 HELX_P B LEU 546 B LEU 28 1 AA2 13 TRANSCRIPTION TRANSCRIPTION FACTOR TFIIH, TRANSACTIVATION DOMAIN, NUCLEAR FACTOR KAPPA-B, TRANSCRIPTIONAL ACTIVATION, P62/TFB1 SUBUNIT, TRANSCRIPTION TFB1_YEAST UNP 1 2 P32776 SHSGAAIFEKVSGIIAINEDVSPAELTWRSTDGDKVHTVVLSTIDKLQATPASSEKMMLRLIGKVDESKKRKDNEGNEVV PKPQRHMFSFNNRTVMDNIKMTLQQIISRYKDAD TF65_HUMAN UNP 2 521 Q04206 PGLPNGLLSGDEDFSSIADMDFSALLSQISS 2 115 5URN 2 115 P32776 A 1 2 115 521 551 5URN 521 551 Q04206 B 2 3 33 1 expression tag PRO 1 5URN A P32776 UNP 1 2 expression tag GLY 519 5URN B Q04206 UNP 1 2 expression tag SER 520 5URN B Q04206 UNP 2 2 LEU engineered mutation TYR 523 5URN B Q04206 UNP 523 5 4 3 2 anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A ALA 7 A ALA 7 A PHE 9 A PHE 9 A VAL 12 A VAL 12 A ASN 19 A ASN 19 A GLU 26 A GLU 26 A SER 31 A SER 31 A VAL 37 A VAL 37 A VAL 41 A VAL 41 A ILE 45 A ILE 45 A ALA 50 A ALA 50 A MET 59 A MET 59 A GLY 64 A GLY 64 A ARG 86 A ARG 86 A SER 90 A SER 90 A ARG 72 A ARG 72 A LYS 73 A LYS 73 A GLU 79 A GLU 79 A VAL 80 A VAL 80 1 P 1